Design and synthesis of alpha-carboxy nucleoside phosphonate analogues and evaluation as HIV-1 reverse transcriptase-targeting agents
dc.contributor.author | Keane, Sarah J. | |
dc.contributor.author | Ford, Alan | |
dc.contributor.author | Mullins, Nicholas D. | |
dc.contributor.author | Maguire, Nuala M. | |
dc.contributor.author | Legigan, Thibaut | |
dc.contributor.author | Balzarini, Jan | |
dc.contributor.author | Maguire, Anita R. | |
dc.contributor.funder | Science Foundation Ireland | en |
dc.contributor.funder | KU Leuven | en |
dc.date.accessioned | 2020-08-31T12:40:57Z | |
dc.date.available | 2020-08-31T12:40:57Z | |
dc.date.issued | 2014-12-22 | |
dc.date.updated | 2020-08-24T14:27:34Z | |
dc.description.abstract | The synthesis of the first series of a new class of nucleoside phosphonate analogues is described. Addition of a carboxyl group at the α position of carbocyclic nucleoside phosphonate analogues leads to a novel class of potent HIV reverse transcriptase (RT) inhibitors, α-carboxy nucleoside phosphonates (α-CNPs). Key steps in the synthesis of the compounds are Rh-catalyzed O–H insertion and Pd-catalyzed allylation reactions. In cell-free assays, the final products are markedly inhibitory against HIV RT and do not require phosphorylation to exhibit anti-RT activity, which indicates that the α-carboxyphosphonate function is efficiently recognized by HIV RT as a triphosphate entity, an unprecedented property of nucleoside monophosph(on)ates. | en |
dc.description.sponsorship | KU Leuven – University of Leuven (PF-10/018) | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Keane, S. J., Ford, A., Mullins, N. D., Maguire, N. M., Legigan, T., Balzarini, J. and Maguire, A. R. (2015) 'Design and Synthesis of α-Carboxy Nucleoside Phosphonate Analogues and Evaluation as HIV-1 Reverse Transcriptase-Targeting Agents', The Journal of Organic Chemistry, 80(5), pp. 2479-2493. doi: 10.1021/jo502549y | en |
dc.identifier.doi | 10.1021/jo502549y | en |
dc.identifier.endpage | 2493 | en |
dc.identifier.issn | 0022-3263 | |
dc.identifier.journaltitle | The Journal of Organic Chemistry | en |
dc.identifier.startpage | 2479 | en |
dc.identifier.uri | https://hdl.handle.net/10468/10417 | |
dc.identifier.volume | 80 | en |
dc.language.iso | en | en |
dc.publisher | American Chemical Society | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Principal Investigator Programme (PI)/05/PICA/B802/IE/Design and Synthesis of Novel Phosphononucleosides - Potential Antiviral Agents/ | en |
dc.relation.uri | https://pubs.acs.org/doi/10.1021/jo502549y | |
dc.rights | © 2014 American Chemical Society. This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Organic Chemistry copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://pubs.acs.org/doi/10.1021/jo502549y | en |
dc.subject | Organophosphorus compounds | en |
dc.subject | Inhibitors | en |
dc.subject | Organic compounds | en |
dc.subject | Nucleic acids | en |
dc.subject | Reaction products | en |
dc.subject | Immunodeficiency-virus type-1 | en |
dc.title | Design and synthesis of alpha-carboxy nucleoside phosphonate analogues and evaluation as HIV-1 reverse transcriptase-targeting agents | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 3 of 3
Loading...
- Name:
- 2015_Keane_J_Org_Chem_11-11-14.docx
- Size:
- 424.17 KB
- Format:
- Microsoft Word XML
- Description:
- Author's original
Loading...
- Name:
- 2015_Keane_J_Org_Chem_11-11-14.pdf
- Size:
- 702.64 KB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted version
Loading...
- Name:
- jo502549y_si_001.pdf
- Size:
- 8.22 MB
- Format:
- Adobe Portable Document Format
- Description:
- Supporting Information
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: